Jingrong Jean Cui, Director at Turning Point Therapeutics, Inc. (TPTX), sold 99,928 shares at $62.50 ($6.4M) on 2020-06-08, disclosed to the SEC on 2020-06-08.
Open-market sale of $6.4M TPTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $61.76 | 1,900 | $117K | 1.8% |
| 2 | $62.70 | 3,600 | $226K | 3.5% |
| 3 | $63.88 | 3,688 | $236K | 3.7% |
| 4 | $63.88 | 3,688 | $236K | 3.7% |
| 5 | $64.67 | 4,012 | $259K | 4.0% |
| 6 | $64.67 | 4,012 |
| $259K |
| 4.0% |
| 7 | $65.81 | 600 | $39K | 0.6% |
| 8 | $67.52 | 1,800 | $122K | 1.9% |
| 9 | $68.62 | 2,072 | $142K | 2.2% |
| 10 | $68.62 | 2,072 | $142K | 2.2% |
| 11 | $69.54 | 828 | $58K | 0.9% |
| 12 | $69.54 | 828 | $58K | 0.9% |
| 13 | $63.04 | 3,602 | $227K | 3.5% |
| 14 | $63.04 | 3,602 | $227K | 3.5% |
| 15 | $64.04 | 8,927 | $572K | 8.9% |
| 16 | $64.04 | 8,927 | $572K | 8.9% |
| 17 | $65.03 | 4,671 | $304K | 4.7% |
| 18 | $65.03 | 4,671 | $304K | 4.7% |
| 19 | $65.66 | 1,300 | $85K | 1.3% |
| 20 | $62.50 | 1,872 | $117K | 1.8% |
| 21 | $63.36 | 10,667 | $676K | 10.5% |
| 22 | $63.36 | 10,667 | $676K | 10.5% |
| 23 | $63.92 | 5,961 | $381K | 5.9% |
| 24 | $63.92 | 5,961 | $381K | 5.9% |
| Total | $64.19 avg | 99,928 | $6.4M | 100% |
| Filing → |
| TPTX | SELL | 2020-05-12 | $1.2M | — | Filing → |
| TPTX | SELL | 2020-05-07 | $5.8M | — | Filing → |
| TPTX | SELL | 2020-04-24 | $1.5M | — | Filing → |